<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR82">
 <label>82.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sgambato</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors</article-title>
  <source>Expert Rev Anticancer Ther</source>
  <year>2018</year>
  <volume>18</volume>
  <issue>1</issue>
  <fpage>71</fpage>
  <lpage>80</lpage>
  <pub-id pub-id-type="doi">10.1080/14737140.2018.1412260</pub-id>
  <?supplied-pmid 29187012?>
  <pub-id pub-id-type="pmid">29187012</pub-id>
 </element-citation>
</ref>
